New Asthma Diagnosis Codes or Short‐Acting β2 Agonist Prescriptions After Histoplasmosis Among Patients With Commercial Health Insurance, United States, 2018–2023 is a research paper published in Mycoses (2025). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Intramural CDC HHS
Grant: CC999999
MeSH Terms
Keywords